Abstract:To detect effects of B7 co-stimulation on cytokines, especially on IL-2 mRNA and transcription factors NF-kappa B and AP-1, antiB7-1 McAb, antiB7-2 McAb and C TLA-4 Ig were added into mixture lymphocyte reaction (MLR) system to block B7/C D28 signal transduction, IL-2 mRNA and IL-4 mRNA were determined by using competitive PCR and IFN-gamma mRNA by using semi-quantitative PCR. MHC class II molecules and B7 transfectants were used to stimulate CD28(+) T cell, effects of B7 on NF-kappa B and AP-1 were detected by DNA-protein binding assay. The results showed that IL-2, IL-4 and IFN-gamma mRNA were significantly lower when blockade of B7-2 in MLR than blockade of B7-1. Synergistic effects could be seen with combination of two or three antibodies. One to six hours after MLR, tDR7 alone induced NF-kappa B binding activity; cotransfecting B7 no significantly difference at early time point. After 6 hours, induction of tDR7 was decreased whereas B7 prolonged the induction of NF-kappa B till 72 hours. tDR7 alone also upregulated AP-1 binding activity, on the contrary to NF-kappa B, co-transfecting B7-1 and B7-2 decreased AP-1 binding activity within 24 hours. But during 48 - 72 hours, B7 also prolonged the AP-1 binding activity. It is concluded that after MLR, B 7 increased IL-2 secretion by decreasing the degradation of IL-2 mRNA and upregulating IL-2 transcription factors. B7 also induced several kinds of cytokines secretion. Effects of B7-1 and B7-2 had no significant difference on transcription factors. It is suggested that the different functions between B7-1 and B7-2 maybe related to the difference of cell expression and kinetics. To study the molecular mechanism of B7 mediated T cell immune tolerance can help us to design a better clinic schema to prevent transplantation rejection and GVHD.

Expressions of B7-H4 in Mouse Myeloid Dendritic Cells and Its Role in Activation of T Lymphocytes

Multiple signaling pathways are involved in the interleukine-4 regulated expression of DC-SIGN in THP-1 cell line.

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

B7-H4 expression in various tumors determined using a novel developed monoclonal antibody

[Expression and identification of recombinant mouse gene B7-H4].

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

High-Level Expression Of B7-H1 Molecules By Dendritic Cells Suppresses The Function Of Activated T Cells And Desensitizes Allergen-Primed Animals

Membranous B7-H1 molecule activates allogenic Tr1 cells and mediates immunosuppression in mice

Aberrant Expression of B7-H4 and BTLA in Tumor Model

B7-H1 enhances Ag-specific lymphocytes proliferation and induces immunosuppressive T cells

The suppressor T cells induced by membranous B7-H1 molecule and their immunobiological properties

[The Identical Effects of B7-1 and B7-2 on Regulation of Human IL-2 Gene Transcription Factors NF-kappa B and AP-1].

B7H1-Ig fusion protein activates the CD4(+) IFN-gamma receptor(+) type 1 T regulatory subset through IFN-gamma-secreting Th1 cells

Experimental study on enhancement of immune function of dendritic cells from peripheral blood of patients with bladder cancer by blocking the B7-H1 pathway

B7H1-Ig Fusion Protein Activates the CD4+ IFN-γ Receptor+ Type 1 T Regulatory Subset through IFN-γ-Secreting Th1 Cells

Mouse Β-Defensin-14 for Inducing the Maturation of Dendritic Cells.

Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model

The Effects of CD40L on the Phenotypes and IL-12 Secretion of B Lymphocytes

Study on the Mechanism Underlying the Immunosuppression Induced by B7H1-Ig Fusion Protein

TGF Β1 Inhibits the Maturation of Dendritic Cells and Down- Regulates TLR4 Expression

CMTM7 Plays Key Roles in TLR-induced Plasma Cell Differentiation and P38 Activation in Murine B-1 B Cells.